{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/MSB.AU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":1.935,"timestamp":1791436320000,"preClose":1.995,"halted":0,"volume":3232575,"delay":0,"changeRate":-0.030075187969924838,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.06379264516777897,"marketStatus":"Not Yet Opened","change":-0.06,"latestTime":"10-08 16:12:00 AEDT","open":1.99,"high":2.04,"low":1.925,"amount":6312384,"amplitude":0.057644,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.06379264516777897,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.995,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":1.199847625635148,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":1.935,"auctionPrice":1.95,"auctionVolume":650,"auctionTime":1791491401093,"referenceTime":1791455403091,"auction":1,"marketStatus":"盘前竞价","timestamp":1791491401093}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-4.11%","roe":"-9.86%","lyrEps":-0.063793,"volumeRatio":1.199847625635148,"shares":1296862776,"dividePrice":0,"high":2.04,"amplitude":0.057644,"preClose":1.995,"low":1.925,"week52Low":1.88,"pbRate":"3.07","psRate":"14.52","week52High":3.31,"institutionHeld":0,"latestPrice":1.935,"eps":-0.06379264516777897,"divideRate":0,"volume":3232575,"delay":0,"ttmEps":-0.06379264516777897,"open":1.99,"prevYearClose":2.72,"prevWeekClose":2.04,"prevMonthClose":2.11,"prevQuarterClose":2.11,"fiveDayClose":2.07,"twentyDayClose":2.17,"sixtyDayClose":2.77,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627424768","title":"ASX April 2026 Stocks Estimated To Be Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2627424768","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627424768?lang=en_us&edition=fundamental","pubTime":"2026-04-15 03:04","pubTimestamp":1776193483,"startTime":"0","endTime":"0","summary":"The Australian stock market is experiencing a period of optimism, with the ASX 200 futures seeing a significant rise as global equities receive a boost from renewed geopolitical negotiations. Amidst this fluctuating landscape, identifying stocks that are trading below their fair value can offer potential opportunities for investors looking to capitalize on market inefficiencies.","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/10930197-main-header/1585187569107","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/10930197-main-header/1585187569107"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/retail/asx-nck/nick-scali-shares/news/asx-april-2026-stocks-estimated-to-be-trading-below-fair-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/retail/asx-nck/nick-scali-shares/news/asx-april-2026-stocks-estimated-to-be-trading-below-fair-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7161","BK7049","BK7043","NCK.AU","BK7153","LGI.AU","BK7067","BK7107","BET.AU","WRK.AU","KGN.AU","BK7051","BK7062","ABV.AU","BK7060","MFG.AU","BK7508","BK7078","SDR.AU","BK7016","BK7501","BK7135","KSL.AU","TPW.AU","MSB.AU","CHL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627337437","title":"Mesoblast director Gregory George buys US$ 10.1 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2627337437","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627337437?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:20","pubTimestamp":1776079231,"startTime":"0","endTime":"0","summary":"Mesoblast director Gregory George reported purchases of ordinary shares, raising indirect beneficial ownership to 13,586,890 shares.Transactions were reported at prices ranging from A$ 1.41 to A$ 1.48 per share.Holdings were reported as held indirectly via James George or Grant George under power of attorney to George.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL1BFvcb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mesoblast director Gregory George buys US$ 10.1 million common shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626889120","title":"Did FDA-Cleared Duchenne Trial for Ryoncil Just Shift Mesoblast's (ASX:MSB) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626889120","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626889120?lang=en_us&edition=fundamental","pubTime":"2026-04-12 04:28","pubTimestamp":1775939339,"startTime":"0","endTime":"0","summary":"Earlier this week, Mesoblast Limited announced that the FDA granted Investigational New Drug clearance to proceed directly to a registrational trial of Ryoncil (remestemcel-L-rknd) in 76 children with Duchenne muscular dystrophy, using time-to-stand at nine months as the primary approval endpoint.\nThis move extends the use of the first FDA-approved mesenchymal stromal cell therapy beyond steroid‑refractory pediatric graft-versus-host disease and leverages a partnership with Parent Project...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/did-fda-cleared-duchenne-trial-for-ryoncil-just-shift-mesobl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/did-fda-cleared-duchenne-trial-for-ryoncil-just-shift-mesobl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7067","MSB.AU","MSB","BK4006","BK4588","LABU","BK7508","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626146145","title":"Mesoblast director Gregory George reports US$ 5.7 million common share purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2626146145","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626146145?lang=en_us&edition=fundamental","pubTime":"2026-04-11 07:28","pubTimestamp":1775863711,"startTime":"0","endTime":"0","summary":"Mesoblast director Gregory George reported purchases of ordinary shares, lifting indirect beneficial ownership held through related parties.Holdings tied to James George rose to 13,586,890 ordinary shares.Holdings tied to Grant George increased to 8,324,072 ordinary shares.Purchase prices in filing ranged from A$ 1.42 to A$ 14.4 per ordinary share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL6hlBfv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mesoblast director Gregory George reports US$ 5.7 million common share purchase","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","MSB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":9,"totalSize":164,"code":"91000000","status":"200"}]}}